Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Alzheimer Disease × Rosiglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Thyroid Cancer, Papillary 1 Solid Cancers 1 Lymphoma, Follicular 1 Diabetes Mellitus, Type 2 1 Carcinoma, Renal Cell 1 Alzheimer Disease 1 Adenocarcinoma, Follicular 1

Interventions

XENP 1595 2 birtamimab 1 UE2343 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Methotrexate 1 Electroencephalography 1 Donepezil 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

GlaxoSmithKline

Phase 3 Completed

862 enrolled 36 charts

Alzheimer Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡